RNU2-60P

Across TCGA pan-cancer cohorts, RNU2-60P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU2-60P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU2-60P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU2-60P expression acts as an unfavorable survival marker.

READ, ESCA, and KIRC are the cancer types where RNU2-60P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	III,IV	0.177	0.798	<.001	48	view →
ESCA	OS	Tertile	All	0.435	0.709	.002	45	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	36	view →
BRCA	OS	Tertile	II,III,IV	0.818	0.916	.012	30	view →
LAML	DFS	Tertile	All	0.111	0.571	.018	18	view →
SKCM	OS	Tertile	All	0.100	0.397	.035	6	view →
LGG	OS	Tertile	All	0.309	0.542	.034	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU2-60P–READ (OS)

Open the READ breakdown →